Drug Profile
Labradimil
Alternative Names: Cereport; Lobradimil; Receptor-mediated permeabiliser 7; RMP-7Latest Information Update: 30 Sep 2014
Price :
$50
*
At a glance
- Originator Alkermes
- Developer Alkermes; ALZA Corporation
- Class Adjuvants; Kinins; Neuropeptides; Oligopeptides
- Mechanism of Action Bradykinin B2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Brain cancer; Cancer metastases; Cryptococcosis; Glioma; HIV infections
Most Recent Events
- 30 Sep 2014 Discontinued - Phase-I for Cryptococcosis (Cryptococcal meningitis) in USA (IV)
- 30 Sep 2014 Discontinued - Phase-I for HIV infections (Cryptococcal meningitis) in USA (IV)
- 30 Sep 2014 Discontinued - Phase-II for Brain cancer in USA (Intra-arterial)